Cell Harvesting Systems Market Size (2025-2030)

The Cell Harvesting Systems Market was valued at USD 6.02 billion and is projected to reach a market size of USD 26.60 billion by the end of 2030. Over the forecast period of 2025-2030, the market is projected to grow at a CAGR of 34.6%.   

Key Market Insights:

• The worldwide cell harvesting systems market is witnessing rapid growth due to rising investments in regenerative medicine and growth in biotechnology and biopharmaceutical industries. The growth is mainly due to the increasing incidence of infectious and chronic diseases, increased demand for stem cell banking, and improved automated cell harvesting technologies.
• The largest market share is currently in North America, thanks to its sophisticated healthcare infrastructure and huge research expenditure.
• Major industry participants like PerkinElmer Inc., Sartorius AG, and Terumo Corporation are emphasizing strategic actions like product development and collaborations to stay competitive in this dynamic market.

Cell Harvesting Systems Market Key Drivers:

The Rise of Automation and AI in Biotechnology is Revolutionizing Cell Harvesting:

The industry is experiencing a transition towards automated cell harvesting systems, which held more than 58% of the market share in 2024. These systems provide improved efficiency, accuracy, and scalability, minimizing manual handling and labor expenses. The incorporation of sophisticated technologies, including artificial intelligence and machine learning, has also optimized cell harvesting processes, rendering them essential in large-scale cell cultures and clinical use.

Advances in Cell Separation Technologies:

Developments like immunomagnetic separation, fluorescence-activated cell sorting (FACS), and microfluidics have dramatically improved the efficacy and accuracy of cell isolation techniques, enabling advancements in regenerative medicine and biotechnology.

Increasing Attention towards Closed and Sterile Systems:

There is mounting interest in designing closed and sterile cell harvesting systems to reduce risks of contamination, guarantee product purity, and adhere to very tight regulatory guidelines for biopharmaceutical manufacturing.

Government and Private Investments in Healthcare R&D:
Increased funding for stem cell research and cell-based therapies from governments and private organizations is accelerating innovation in cell harvesting technologies.

Growing Demand for Regenerative Medicine and Stem Cell Research:

Increased focus on regenerative therapies and stem cell-based treatments for diseases like neurodegenerative disorders and cardiovascular conditions is boosting the demand for efficient cell harvesting systems.

Advancements in Biotechnology and Automation:

Cutting-edge technologies, such as automated cell harvesting systems, are enhancing precision, reducing contamination risks, and improving cell viability.

Rising Prevalence of Chronic Diseases:

The increasing incidence of cancer, autoimmune diseases, and organ failures is driving the need for cell-based therapies, which require high-quality harvesting solutions.

Expansion of Biopharmaceutical and Cell Therapy Industries:

Growth in biologics, gene therapy, and personalized medicine is fueling the adoption of advanced cell harvesting techniques for research and clinical applications.

Cell Harvesting Systems Market Restraints and Challenges:

The market for cell harvesting systems encounters several challenges that might hinder its progress. The prohibitive costs linked with the deployment of advanced cell harvesting technologies pose a barrier, particularly for smaller and medium research institutions and clinics. The fact that the methodologies are usually highly complex often implies the need for specialized skills and equipment, and such might not be available within all environments. Ethical and legislative issues, notably concerning the use of some cell sources such as embryonic stem cells, complicate the scene even further since tight controls exist around cell harvesting and use. In addition, the absence of standard protocols for cell collection is liable to generate variability in the viability and performance of cells and, therefore, in the general efficacy of cell-derived therapies. These conditions all individually and collectively represent strong restraints and challenges to the widespread development and implementation of cell harvesting systems.

Cell Harvesting Systems Market Opportunities:

The cell harvesting systems market is on the cusp of rapid growth, thanks to advances in regenerative medicine, stem cell research, and personalized medicine. The rise of chronic diseases has increased the need for cell-based therapies, which require effective and accurate cell harvesting systems. Advances in technology, especially the combination of automation and artificial intelligence, have improved the efficiency and scalability of these systems and made them integral to contemporary laboratories. Yet, issues like exorbitant prices and complicated regulatory environments continue to exist, particularly in emerging market economies.

CELL HARVESTING SYSTEMS MARKET REPORT COVERAGE:

Cell Harvesting Systems Market Segmentation:

Cell Harvesting Systems Market  Segmentation  By Type:

• Manual Systems
• Automated Systems

In the market for cell harvesting systems, automated systems are growing rapidly and dominating the market more and more. They provide increased efficiency, accuracy, and uniformity, significantly minimizing the potential for human error and contamination when compared to manual procedures. Automated cell harvesters are especially useful in high-throughput applications like biopharmaceutical production and high-volume research, where they reduce complexity and increase productivity. Their incorporation with innovative technologies, such as robotics and artificial intelligence, only increases their utility, making them an essential feature in contemporary laboratories. Though manual systems are still common because of their affordability and ease of use, particularly in smaller research facilities and in developing countries, the direction is fast leaning toward automation. This is particularly prompted by the growing need for scalable and reproducible cell harvesting solutions in the pharmaceutical and biotechnology sectors.

Cell Harvesting Systems Market  Segmentation By Application:

• Umbilical Cord
• Bone Marrow
• Peripheral Blood
• Adipose Tissue
• Others

In the market for cell harvesting systems, peripheral blood applications have become the leading segment, representing more than 55% of the market share in 2024. This is due to the minimally invasive procedure of peripheral blood stem cell (PBSC) collection and the increasing demand for stem cell therapies. Also, the segment of adipose tissue is growing at the fastest rate with a compound annual growth rate (CAGR) of 14.46 % anticipated in the forthcoming years. The high growth rate is spurred by the ease of obtaining adipose-derived stem cells and their enormous potential for application in regenerative medicine.

Cell Harvesting Systems Market  Segmentation By End User:

• Hospitals
• Clinics
• Academic Institutes
• Research & Development Centers

In the market for cell harvesting systems, hospitals at present command the highest share, driven mainly by their comprehensive infrastructure and the huge number of stem cell harvesting procedures carried out for transplantation as well as research applications. Academic institutes and research & development centers are growing at the fastest rate, though. This growth is fueled by greater investments in research programs by universities and biopharmaceutical firms, in addition to a growing demand for regenerative medicine and stem cell therapies. These developments highlight the critical role played by academic and R&D centers in pushing cell harvesting technologies and applications forward.

Cell Harvesting Systems Market Regional Analysis:

The cell harvesting systems market is geographically unique, with North America taking the lead with a dominant share. The region is powered by a developed healthcare infrastructure, high investments in biotechnology research, and strong demand for cell-based therapies. Europe comes second, supported by a robust emphasis on healthcare innovation, collaboration between academia and industry, and rising government funding for regenerative therapies. The Asia Pacific is witnessing fast-paced growth driven by increased healthcare spending, heightened awareness of sophisticated therapies, and rising incidences of chronic diseases in China and India. Latin America and the Middle East & Africa, though currently positioned with smaller market shares, will witness slow but steady growth due to investment in healthcare infrastructure and an expanding need for sophisticated medical therapies.

COVID-19 Impact Analysis on the Cell Harvesting Systems Market:

The COVID-19 pandemic has had a multi-dimensional effect on the cell harvesting systems market. In the first instance, the pandemic caused major disruptions, such as suspended production and logistical issues, as businesses followed social distancing guidelines and experienced movement restrictions. The pandemic also highlighted the importance of cell-based therapies in responding to health emergencies, with more investments and research in regenerative medicine and stem cell-based therapies. This new emphasis is expected to propel technological innovation and market expansion in the cell harvesting industry in the next few years.

Recent Trends/Developments:

Recent developments in the cell harvesting systems market have centered on increasing efficiency and scalability to address the increasing demand for cell-based therapies. One of the developments is the investigation of acoustophoresis-based systems for high-throughput washing of cells, which use acoustic forces to transport cells between streams with high rates of medium exchange and cell recovery. This technique has been shown to enhance downstream processing operations, like washing and harvesting cells, through continuous processing features and minimal intervention. These innovations seek to optimize cell manufacturing procedures, thus minimizing production costs and making the industrialization of cell-based therapies feasible.

Advancements in automated and closed-system cell harvesting technologies are enhancing efficiency and reducing contamination risks. For instance, in February 2023, TheWell Bioscience introduced the VitroGel Organoid Recovery Solution, designed to recover organoids and cells more efficiently, reducing processing time significantly.

Strategic Partnerships and Investments: Companies are engaging in collaborations and securing funding to expand their capabilities. In March 2024, Terumo Blood and Cell Technologies partnered with the CiRA Foundation to promote the use of induced pluripotent stem (iPS) cells for new therapies. ​

Key Players in the Cell Harvesting Systems  Market:

1. PerkinElmer, Inc
2. Sartorius AG
3. Terumo Corporation
4. Thermo Fisher Scientific Inc.
5. Miltenyi Biotec
6. Lumenis Ltd. (Israel)
7. Danaher Corporation
8. AVITA Medical
9. Arthrex, Inc.
10. Tomtec
11. Teleflex Incorporated